Bone repair stem cell therapy - Forticell Bioscience

Drug Profile

Bone repair stem cell therapy - Forticell Bioscience

Alternative Names: fibrin-microbead

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ortec International
  • Class
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Fracture

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Fracture in USA (Intralesional, Implant)
  • 10 Jan 2008 Ortec International is now called Forticell Bioscience
  • 22 Jun 2006 Preclinical trials in Bone regeneration in USA (Implant)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top